EMR vs FORM vs KLAC Stock Comparison

Emerson Electric, Formfactor and Kla Prices as of Oct 28, 2026 Peers: Industry group
1 more company in this comparison (PH) Create a free account to keep reading and compare up to 10 companies.
EMR Emerson Electric Co
$167.78 +5.3% 1M +24.7% 1Y
Market cap
$93.59B
P/E
36.4x
Revenue (TTM)
$18.64B
Div. yield
1.33%
Pumps and Valves Industrials
4 wins
FORM Formfactor Inc
$110.31 -15.8% 1M +160.0% 1Y
Market cap
$8.62B
P/E
49.6x
Revenue (TTM)
$980.10M
Div. yield
–
Test and Measurement Technology
3 wins
KLAC Kla Corp
$158.77 -16.1% 1M +31.6% 1Y
Market cap
$207.51B
P/E
41.5x
Revenue (TTM)
$14.06B
Div. yield
0.29%
Semiconductor Equipment Technology
2 wins

Head to Head

9 decided of 12

Emerson Electric leads on 4 of the 12 questions below (Emerson Electric 4, Formfactor 3, Kla 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionEMRFORMKLACLeader
Larger companyMarket capitalisation $93.59B $8.62B $207.51B KLAC
Cheaper on earningsLower P/E, profitable companies only 36.4x 49.6x 41.5x EMR
Cheaper on forward earningsLower price / next fiscal year consensus EPS 24.9x 35.0x 28.0x EMR
Faster revenue growthRevenue growth, trailing twelve months +4.8% +29.1% +12.2% FORM
More profitableNet margin, trailing twelve months 13.8% — — –
Better return on capitalReturn on invested capital 10.9% — — –
Less leveragedLower net debt / EBITDA 1.8x — — –
Higher dividend yieldTrailing dividend yield 1.33% — 0.29% EMR
Better 1-year returnPrice return, last 12 months +24.7% +160.0% +31.6% FORM
Better 5-year returnAnnualised price return, 5 years +11.6%/yr +22.6%/yr +33.6%/yr KLAC
Less volatileAnnualised volatility, 1 year 31.8% 87.2% 61.5% EMR
Higher overall scoreMean of the five percentile scores vs peers 45/100 72/100 43/100 FORM

Percentile Scorecard

EMRFORMKLAC

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisEMRFORMKLAC
Valuation 33 #136 of 203 32 #76 of 111 36 #61 of 94
Growth 39 #115 of 188 97 #4 of 108 54 #43 of 92
Profitability 87 #25 of 184 73 #29 of 104 92 #8 of 90
Financial Health 30 #153 of 217 88 #15 of 115 5 #94 of 99
Shareholder Returns 37 #97 of 153 – 29 #52 of 73
Overall 45 72 43
  • EMR ranked among 222 companies in Machinery
  • FORM ranked among 121 companies in Computer Hardware
  • KLAC ranked among 103 companies in Semiconductors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodEMRFORMKLACSPY
1 month +5.3%-15.8%-16.1% +0.9%
3 months +15.1%+32.2%-6.7% +5.9%
6 months +22.9%-18.6%-12.6% +8.5%
Year to date +26.4%+97.8%+30.7% +13.3%
1 year +24.7%+160.0%+31.6% +12.4%
3 years +90.6%+238.6%+246.7% +88.1%
3 years, per year +24.0%+50.2%+51.4% +23.5%
5 years +73.0%+177.3%+325.9% +68.2%
5 years, per year +11.6%+22.6%+33.6% +11.0%
10 years +235.0%+1,097.7%+2,026.6% +263.4%
10 years, per year +12.9%+28.2%+35.8% +13.8%

Risk

MeasureEMRFORMKLACSPY
Volatility, 1Y 31.8%87.2%61.5% 12.7%
Downside volatility, 1Y 33.5%87.7%65.7% 12.7%
Beta vs S&P 500, 1Y 1.543.002.80 1.00
Return / volatility, 1Y 0.781.840.51 0.98
Max drawdown, 5Y -29.9%-62.7%-51.7% -25.4%
From 52-week high 0.0%-31.0%-47.4% -0.9%
52-week high $167.78$159.93$301.71 $779.14
52-week low $123.30$42.42$109.71 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleEMRFORMKLAC
P/E now vs peer median 36.4xmedian 25.4x 49.6xmedian 33.5x 41.5xmedian 46.0x
P/S now vs peer median 5.0xmedian 1.9x 8.8xmedian 2.8x 14.8xmedian 7.9x
EV/EBITDA now vs peer median 17.0xmedian 14.3x —median 19.6x —median 28.3x
P/FCF now vs peer median 27.0xmedian 21.8x 74.4xmedian 29.8x 68.2xmedian 41.4x
P/B now vs peer median 4.6xmedian 2.2x 7.3xmedian 2.9x 31.8xmedian 4.6x
PEG now vs peer median -0.88median 1.41 0.25median 1.10 2.20median 2.30

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsEMRFORMKLAC
Revenue $18.64B $980.10M $14.06B
Gross profit $9.91B $461.88M –
Operating income $4.68B $179.53M –
Net income $2.58B $173.63M $5.02B
Free cash flow $3.46B – –
R&D – $121.79M $1.53B
EPS (diluted) $4.59 $2.18 $3.80
Cash & equivalents $2.18B $138.18M $1.53B
Total debt $13.11B – –
Shares (diluted) 561.10M 79.61M 1.32B
Enterprise value $86.34B $8.62B $207.51B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricEMRFORMKLAC
P/E 36.4x 49.6x 41.5x
P/FCF 27.0x 74.4x 68.2x
P/Operating cash flow 23.9x 33.5x 43.5x
P/S 5.0x 8.8x 14.8x
P/B 4.6x 7.3x 31.8x
P/Tangible book 8.0x 7.4x 32.9x
EV/EBITDA 17.0x – –
EV/EBIT 22.4x – –
EV/Revenue 5.6x 8.8x 14.8x
EV/FCF 30.2x – –
EV/Operating cash flow 26.7x 33.5x 43.5x
PEG (3Y EPS CAGR) -0.88 0.25 2.20

Growth

14 metrics
MetricEMRFORMKLAC
Revenue growth (1Y) 4.8% 29.1% 12.2%
Revenue CAGR (3Y) 7.6% 14.0% 11.4%
Gross profit growth (1Y) 5.7% 58.4% –
Gross profit CAGR (3Y) 11.0% 25.1% –
Operating income growth (1Y) 9.2% 333.3% –
Operating income CAGR (3Y) 13.6% 143.4% –
Net income growth (1Y) -3.0% 325.1% 18.4%
Net income CAGR (3Y) -42.0% 196.9% 17.4%
EPS growth (1Y) -2.2% 315.1% 18.8%
EPS CAGR (3Y) -41.6% 195.5% 18.9%
Operating cash flow growth (1Y) 4.4% 144.0% 12.2%
Operating cash flow CAGR (3Y) 10.1% 50.0% 10.4%
Free cash flow growth (1Y) 4.4% – –
Free cash flow CAGR (3Y) 9.4% – –

Profitability

14 metrics
MetricEMRFORMKLAC
Gross margin 53.2% – –
EBITDA margin 33.1% – –
Operating margin 25.1% – –
Pretax margin 17.6% – –
Net margin 13.8% – –
FCF margin 18.6% – –
Operating cash flow margin 21.0% 26.2% 33.9%
Return on equity 12.7% 14.8% 77.9%
Return on assets 6.1% 12.2% 27.6%
Return on invested capital 10.9% – –
Return on capital employed 14.9% – –
Asset turnover 0.4x 0.7x 0.8x
Cash conversion (OCF / net income) 1.5x 1.5x 1.0x
Stock comp / revenue 1.3% 3.6% 2.2%

Financial Health

11 metrics
MetricEMRFORMKLAC
Debt / assets 31.1% – –
Debt / equity 0.6x – –
Net debt / EBITDA 1.8x – –
Debt / FCF 3.8x – –
Liabilities / assets 51.7% 17.5% 64.6%
Equity / assets 48.3% 82.5% 35.4%
Interest coverage – – –
Current ratio 0.9x 3.7x 2.8x
Quick ratio 0.5x – –
Cash ratio 0.2x – –
Altman Z-score 4.73 – –

Shareholder Returns

7 metrics
MetricEMRFORMKLAC
Dividend yield 1.3% – 0.3%
Net buyback yield 1.0% – –
Shareholder yield 2.3% – 0.3%
Payout ratio (earnings) 47.8% – –
Payout ratio (FCF) 35.6% – –
Dividend growth (1Y) 3.1% – –
Dividend CAGR (3Y) 0.7% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusEMRFORMKLAC
Forward P/E 24.9xFY2026 35.0xFY2026 28.0xFY2027
EPS, next fiscal year $6.75FY2026 $3.15FY2026 $5.67FY2027
EPS growth, next FY +12.5%FY2026 +142.3%FY2026 +50.8%FY2027
EPS growth, the year after +15.3% +31.4% +16.6%
Revenue, next fiscal year $18.13BFY2026 $982.39MFY2026 $19.18BFY2027
Revenue growth, next FY +0.6%FY2026 +25.1%FY2026 +41.2%FY2027
Revenue growth, the year after +15.3% +21.5% +8.6%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersEMRFORMKLAC
Held by institutions 82.1% 92.0% 91.0%
Institutions holding 2,291 509 2,478
Change in shares held, QoQ +0.9% -3.7% +4.2%
Institutions buying 1,081 304 1,285
Institutions selling 798 168 982
Buyers to sellers 1.35 1.81 1.31

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

EMRFORMKLAC
EMR 1.00 0.36 0.49
FORM 0.36 1.00 0.71
KLAC 0.49 0.71 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, EMR, FORM and KLAC?

Kla (KLAC) is the largest by market capitalisation: Emerson Electric (EMR) $93.59B, Formfactor (FORM) $8.62B, Kla (KLAC) $207.51B.

Which stock is cheaper, EMR, FORM and KLAC?

Emerson Electric (EMR) trades on the lowest price-to-earnings ratio (Emerson Electric (EMR) 36.4x, Formfactor (FORM) 49.6x, Kla (KLAC) 41.5x). On next year's consensus earnings, Emerson Electric (EMR) is cheapest (Emerson Electric (EMR) 24.9x, Formfactor (FORM) 35.0x, Kla (KLAC) 28.0x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Formfactor (FORM) grew revenue fastest over the trailing twelve months: Emerson Electric (EMR) +4.8%, Formfactor (FORM) +29.1%, Kla (KLAC) +12.2%.

Which stock has performed better?

Over the past year Formfactor (FORM) returned the most: Emerson Electric (EMR) +24.7%, Formfactor (FORM) +160.0%, Kla (KLAC) +31.6%. Over five years, Kla (KLAC) compounded fastest (Emerson Electric (EMR) +11.6%/yr, Formfactor (FORM) +22.6%/yr, Kla (KLAC) +33.6%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Emerson Electric (EMR) has the highest dividend yield: Emerson Electric (EMR) 1.33%, Kla (KLAC) 0.29%. Formfactor (FORM) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Emerson Electric (EMR) has been the steadiest (Emerson Electric (EMR) 31.8%, Formfactor (FORM) 87.2%, Kla (KLAC) 61.5%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, EMR, FORM and KLAC?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Emerson Electric (EMR) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.